Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Terrapin and Taiho sign development agreement for anticancer agent

Aug. 18, 1997

Xechem granted patent for paclitaxel isolation and purification method

Aug. 14, 1997

Paclitaxel combination therapy in lung cancer

Aug. 14, 1997

Taxotere cleared in four additional countries

Aug. 13, 1997

MMP inhibitors described by Agouron

Aug. 13, 1997

EntreMed and the National Cancer Institute sign letters of intent

Aug. 12, 1997

Oncormed allowed U.S. patent for BRCA1 gene

Aug. 11, 1997

Bristol-Myers Squibb acquires broad-spectrum antitumor agents

Aug. 11, 1997

Protein kinase C inhibitors discovered at Cephalon

Aug. 8, 1997

Update on Proleukin regulatory status; Photofrin approved in Germany

Aug. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.